Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
679.00    -6.00 (-0.88%)
Bid:
678.00
Ask:
680.00
Spread: 2.00 (0.295%)
Market Cap: £659.45m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Trading Update

19 Apr 2011 07:00

RNS Number : 1357F
Acal PLC
19 April 2011
 



For Release

7.00am, 19 April 2011

 

 

Acal plc

Fourth Quarter Trading Update

Continuing strong growth with Group like for like sales1 up 17%

 

Acal plc (LSE : ACL, "The Group"), the European specialist provider of technology products and services, is today issuing a trading update for its year ended 31 March 2011, ahead of the announcement of its preliminary results on 1 June 2011.

 

The Board is pleased to report that, since its second interim management statement on 3 February 2011, trading has continued to remain strong. In the fourth quarter ended 31 March 2011, Group like for like sales1 increased by 17% year on year.

 

Group sales continue to be driven by a strong Electronics order book. The Electronics division (which accounts for approximately 78% of Group sales) reported a fourth quarter increase in like for like sales1 of 21% despite more challenging comparators.

 

Sales of products manufactured in Japan (all of which are in the Electronics division and represent approximately 4% of Group revenues), were not significantly impacted by the earthquake in mid March and Acal has continued to meet its customers' needs. 

 

The acquisition of Compotron GmbH ("Compotron"), a specialist provider of electronic communication components, was completed with effect from 1 January 2011. Since the acquisition, Compotron has performed well and ahead of our expectations.

 

In the non-Electronics businesses (approximately 22% of Group sales), total like for like sales1 in the fourth quarter were up 7%.

 

As a result, we expect full year results for this year to be ahead of our previous expectations.

 

Nick Jefferies, Group Chief Executive commented:

 

"We continue to see good trading conditions in the Electronics Division across Europe. With its strong order book, Electronics like for like sales1 increased by 21% in the last quarter.

 

Overall, Group sales increased by 17%, with the non-Electronics businesses showing improved performance despite continued softness in our UK Medical business.

 

The Board remains confident that our strategy for growth both organically and by further targeted acquisitions will continue to build long term value for shareholders."

For further information please contact:

Acal plc

Nick Jefferies - Group Chief Executive

Simon Gibbins - Group Finance Director

 

Cubitt Consulting

Chris Lane / Alice Coubrough

01483 544500

 

 

 

020 7367 5100

 

 

 

Notes to the Trading Update

1. Like for like sales are at constant exchange rates, including acquisitions for the whole of the comparative period and excluding the ATM Parts business (effective disposal date 30 September 2010) and a material non-core Supply Chain contract terminated at the end of the last financial year. Compotron, which was acquired in the fourth quarter, has not been included in like for like sales.

 

 Notes to Editors:

 

About Acal plc

The Acal Group is a leading technology-based specialist distributor in Europe providing sales, marketing and other services through three divisions: Electronics, Supply Chain and Medical. The Electronics Division distributes electronic and photonic products to industrial manufacturing and design companies. The Supply Chain Division provides inventory optimisation and outsource solutions to leading technology service providers while the Medical Division supplies advanced medical equipment to public and private healthcare providers. Acal has operating companies in the UK, Netherlands, Belgium, Germany, France, Italy, South Africa, Spain and the Nordic region.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDKFDQABKDOQD
Date   Source Headline
1st Sep 202210:17 amRNSNotification of Major Holdings
26th Aug 20222:27 pmRNSNotification of Major Holdings
22nd Aug 202210:21 amRNSNotification of Major Holdings
29th Jul 20224:23 pmRNSNotification of Major Holdings
28th Jul 20223:00 pmRNSResults of Annual General Meeting
28th Jul 20227:00 amRNSTrading Update
6th Jul 20227:00 amRNSAcquisition of the CDT group
27th Jun 20223:44 pmRNSDirector / PDMR Shareholding
24th Jun 20221:00 pmRNSAnnual Report and Notice of AGM
24th Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 20229:58 amRNSDirector LTIP Award
15th Jun 20228:03 amRNSNotification of Major Holdings
14th Jun 20227:00 amRNSPreliminary results
6th Jun 20227:00 amRNSNotice of Full Year Results
19th May 20222:38 pmRNSNotification of Major Holdings
11th May 20227:00 amRNSDirector/PDMR Shareholding
9th May 20227:00 amRNSDirector/PDMR Shareholding
21st Apr 202210:57 amRNSTR-1: Notification of Major Holdings
14th Apr 20227:00 amRNSFull Year Trading Update
7th Apr 20227:00 amRNSdiscoverIE Awarded “A” Rating by MSCI ESG
29th Mar 20224:29 pmRNSDirector/PDMR Shareholding
22nd Mar 20227:00 amRNSDirector Declaration
10th Mar 20223:02 pmRNSHolding(s) in Company
9th Mar 20227:00 amRNSHolding(s) in Company
4th Mar 20227:00 amRNSCompletion of Distribution Businesses Disposals
25th Feb 20229:50 amRNSDirector/PDMR Shareholding
9th Feb 20227:00 amRNSTrading Update
9th Feb 20227:00 amRNSChange to Operating Segments
10th Dec 20213:49 pmRNSDirector/PDMR Shareholding
8th Dec 20218:50 amRNSDirector/PDMR Shareholding
6th Dec 20218:30 amRNSIssue of Equity & Total Voting Rights
30th Nov 20217:00 amRNSInterim Results
22nd Nov 20214:05 pmRNSHolding(s) in Company
11th Nov 202112:49 pmRNSNotice of Half Year Results
9th Nov 20217:00 amRNSSale of Acal BFi Distribution Business
4th Nov 20217:00 amRNSAppointment of Non-Executive Director
14th Oct 20217:00 amRNSFirst Half Trading Update
4th Oct 20217:00 amRNSSale of Vertec SA
9th Sep 202110:44 amRNSHolding(s) in Company
3rd Sep 20217:00 amRNSResults of Placing
2nd Sep 20215:40 pmRNSAcquisitions & Proposed Placing
5th Aug 20215:30 pmRNSAggreko
30th Jul 20212:06 pmRNSDirector LTIP Award
29th Jul 20214:09 pmRNSResults of Annual General Meeting
29th Jul 20217:00 amRNSTrading Update
28th Jun 202110:09 amRNSHolding(s) in Company
25th Jun 20215:24 pmRNSDirector / PDMR Shareholding
16th Jun 202110:00 amRNSAnnual Report and AGM Notice
3rd Jun 20217:00 amRNSPreliminary results
18th May 20219:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.